Matches in SemOpenAlex for { <https://semopenalex.org/work/W1918302012> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W1918302012 endingPage "1173" @default.
- W1918302012 startingPage "1170" @default.
- W1918302012 abstract "Of the cephalosporins, cefpodoxime has the most published clinical data for the treatment of urinary tract infections. In 2014, the Clinical and Laboratory Standards Institute (CLSI) guidelines recommended that cefazolin should be used as the surrogate marker for cefpodoxime among urinary tract isolates, replacing cephalothin. This study attempted to determine how well cefazolin serves as the surrogate marker. Additionally, it investigated how cefuroxime compared with cefazolin as a surrogate marker. The MicroScan Walkaway Plus system was used to determine susceptibility for cefazolin and cefuroxime on consecutive urine cultures with a colony count of ≥ 50 000 organisms. Only Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis isolates were included, following CLSI guidelines. Simultaneously, an Etest for cefpodoxime was conducted. The cefpodoxime interpretation was compared with that of the other two agents, and the categorical agreement was calculated, defined as the percentage of identical susceptibility interpretations. Cefazolin (92 %) had a significantly higher categorical agreement than cefuroxime (85 %) among 284 isolates (P = 0.011). The major error rate was 4.4 % for cefazolin and 1.1 % for cefuroxime. The very major error rate was 64 % for cefazolin and 18 % for cefuroxime among the 11 cefpodoxime-resistant isolates. Cefazolin was a better predictor of cefpodoxime susceptibility than the previously recommended agent, cephalothin. However, cefuroxime had better major and very major error rates than cefazolin." @default.
- W1918302012 created "2016-06-24" @default.
- W1918302012 creator A5076558151 @default.
- W1918302012 creator A5083105534 @default.
- W1918302012 creator A5091346353 @default.
- W1918302012 date "2015-10-01" @default.
- W1918302012 modified "2023-10-17" @default.
- W1918302012 title "Evaluation of cefazolin as a surrogate marker for cefpodoxime susceptibility for urinary tract isolates" @default.
- W1918302012 cites W1994159952 @default.
- W1918302012 cites W1996192073 @default.
- W1918302012 cites W2083317144 @default.
- W1918302012 cites W2097807888 @default.
- W1918302012 cites W2120750073 @default.
- W1918302012 cites W2126337988 @default.
- W1918302012 cites W2160334804 @default.
- W1918302012 cites W2167539480 @default.
- W1918302012 doi "https://doi.org/10.1099/jmm.0.000142" @default.
- W1918302012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26219948" @default.
- W1918302012 hasPublicationYear "2015" @default.
- W1918302012 type Work @default.
- W1918302012 sameAs 1918302012 @default.
- W1918302012 citedByCount "2" @default.
- W1918302012 countsByYear W19183020122016 @default.
- W1918302012 countsByYear W19183020122017 @default.
- W1918302012 crossrefType "journal-article" @default.
- W1918302012 hasAuthorship W1918302012A5076558151 @default.
- W1918302012 hasAuthorship W1918302012A5083105534 @default.
- W1918302012 hasAuthorship W1918302012A5091346353 @default.
- W1918302012 hasBestOaLocation W19183020121 @default.
- W1918302012 hasConcept C2777499651 @default.
- W1918302012 hasConcept C2777514703 @default.
- W1918302012 hasConcept C2778353156 @default.
- W1918302012 hasConcept C501593827 @default.
- W1918302012 hasConcept C64778159 @default.
- W1918302012 hasConcept C71924100 @default.
- W1918302012 hasConcept C86803240 @default.
- W1918302012 hasConcept C89423630 @default.
- W1918302012 hasConceptScore W1918302012C2777499651 @default.
- W1918302012 hasConceptScore W1918302012C2777514703 @default.
- W1918302012 hasConceptScore W1918302012C2778353156 @default.
- W1918302012 hasConceptScore W1918302012C501593827 @default.
- W1918302012 hasConceptScore W1918302012C64778159 @default.
- W1918302012 hasConceptScore W1918302012C71924100 @default.
- W1918302012 hasConceptScore W1918302012C86803240 @default.
- W1918302012 hasConceptScore W1918302012C89423630 @default.
- W1918302012 hasIssue "10" @default.
- W1918302012 hasLocation W19183020121 @default.
- W1918302012 hasLocation W19183020122 @default.
- W1918302012 hasOpenAccess W1918302012 @default.
- W1918302012 hasPrimaryLocation W19183020121 @default.
- W1918302012 hasRelatedWork W1556314534 @default.
- W1918302012 hasRelatedWork W1918302012 @default.
- W1918302012 hasRelatedWork W1981958397 @default.
- W1918302012 hasRelatedWork W2049794249 @default.
- W1918302012 hasRelatedWork W2133913909 @default.
- W1918302012 hasRelatedWork W2162589476 @default.
- W1918302012 hasRelatedWork W2172073916 @default.
- W1918302012 hasRelatedWork W2280713920 @default.
- W1918302012 hasRelatedWork W2398199009 @default.
- W1918302012 hasRelatedWork W3004731471 @default.
- W1918302012 hasVolume "64" @default.
- W1918302012 isParatext "false" @default.
- W1918302012 isRetracted "false" @default.
- W1918302012 magId "1918302012" @default.
- W1918302012 workType "article" @default.